Conformis

Conformis P/S 2024

Conformis P/S

0.27

Conformis Dividend yield

Ticker

CFMS

ISIN

US20717E1010

WKN

A14T0Y

As of Jun 4, 2024, Conformis's P/S ratio stood at 0.27, a 92.86% change from the 0.14 P/S ratio recorded in the previous year.

The Conformis P/S history

Conformis Aktienanalyse

What does Conformis do?

Conformis Inc is a medical technology company that specializes in the development, manufacturing, and marketing of customized implantable joint prostheses. The company is based in the United States and has its headquarters in Billerica, Massachusetts. History: Conformis Inc was founded in 2004 by Dr. Philipp Lang, an orthopedic surgeon and pioneer in the development of customized implants. The company's goal was to develop an innovative technology that could be used to manufacture individual prostheses for patients. Initially, Conformis focused on the development of custom prostheses for the knee joint. Over the years, the company has expanded its offerings to include other joints such as the hip. Business model: Conformis' business model is based on providing customized, implantable prostheses. Unlike traditional prostheses that are available in standard sizes, Conformis prostheses are individually manufactured for each patient. The company uses advanced 3D printing technology to produce a prosthesis that matches the specific anatomical features of the patient. Conformis prostheses offer numerous advantages over conventional prostheses. By customizing the prosthesis, a better fit and higher stability can be achieved. This can lead to better function and increased lifespan of the prosthesis. Additionally, Conformis prostheses can be implanted faster and more easily than traditional prostheses. Divisions: Conformis offers a variety of products for different joints. Knee prostheses: Conformis offers a wide range of custom knee prostheses. The offerings include partial replacement prostheses that only replace a part of the knee, as well as complete knee prostheses. All prostheses are individually manufactured for each patient to ensure optimal fit and function. Hip prostheses: Conformis also offers custom prostheses for the hip. These prostheses are designed to provide high stability and better fit. The hip prostheses are also individually made for each patient. Shoulder prostheses: Conformis offers custom prostheses for the shoulder, which are also tailored to the patient's anatomy. These prostheses can be used for rotator cuff defects as well as other shoulder problems. Products: The core product of Conformis is custom joint prostheses. The company's prostheses are individually manufactured for each patient to ensure optimal fit and function. Advanced technologies such as 3D printing and digital imaging are used in the production process. Conformis also offers implants for specialized procedures such as medial knee replacement. In addition to the prostheses, Conformis also offers implants such as screws, pins, and plates that can be used to fix bones during surgery. Conclusion: Conformis is a leading company in the medical technology field and offers specialized products that cater to the needs of patients. The company specializes in customized implantable joint prostheses and offers a wide range of products that are tailored to the needs of patients. Conformis has earned an excellent reputation in the industry and continues to strive to develop innovative products that improve the lives of patients. Conformis ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Conformis's P/S Ratio

Conformis's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Conformis's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Conformis's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Conformis’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Conformis Stock

What is the price-to-earnings ratio of Conformis?

The price-earnings ratio of Conformis is currently 0.27.

How has the price-earnings ratio of Conformis changed compared to last year?

The price-to-earnings ratio of Conformis has increased by 92.86% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Conformis high compared to other companies?

Yes, the price-to-earnings ratio of Conformis is high compared to other companies.

How does an increase in the price-earnings ratio of Conformis affect the company?

An increase in the price-earnings ratio of Conformis would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Conformis affect the company?

A decrease in the price-earnings ratio of Conformis would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Conformis?

Some factors that influence the price-earnings ratio of Conformis are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Conformis pay?

Over the past 12 months, Conformis paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Conformis is expected to pay a dividend of 0 USD.

What is the dividend yield of Conformis?

The current dividend yield of Conformis is .

When does Conformis pay dividends?

Conformis pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Conformis?

Conformis paid dividends every year for the past 0 years.

What is the dividend of Conformis?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Conformis located?

Conformis is assigned to the 'Health' sector.

Wann musste ich die Aktien von Conformis kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Conformis from 6/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/4/2024.

When did Conformis pay the last dividend?

The last dividend was paid out on 6/4/2024.

What was the dividend of Conformis in the year 2023?

In the year 2023, Conformis distributed 0 USD as dividends.

In which currency does Conformis pay out the dividend?

The dividends of Conformis are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Conformis stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Conformis

Our stock analysis for Conformis Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Conformis Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.